← Companies
Celldex Therapeutics, Inc.
Data as of Nov 1, 2026
CLDX
CIK 744218Lobbying
$350,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$270K5 filings
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Health Issues Issues related to mast cell conditions and therapies; Issues related to drug development and biopharma ecosystem. | $90,000 |
| Apr 20, 2026 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Unspecified | $60,000 |
| Jan 20, 2026 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Health Issues Issues related to NIH-funded research; Issues related to mast cell conditions and therapies. | $60,000 |
| Oct 20, 2025 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Health Issues Issues related to NIH-funded eosinophilic gastrointestinal disease research; Issues related to mast cell conditions and therapies. | $60,000 |
| Jul 21, 2025 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Health Issues Issues related to NIH-funded eosinophilic gastrointestinal disease research. | $60,000 |
| Apr 21, 2025 | AKIN GUMP STRAUSS HAUER & FELD for CELLDEX THERAPEUTICS INC. Unspecified | $20,000 |